 In 2018 it gained its first approvals for use as food.Plants and plant cells have been genetically engineered for production of biopharmaceuticals in bioreactors, a process known as pharming.Work has been done with duckweed "Lemna minor", the algae "Chlamydomonas reinhardtii" and the moss "Physcomitrella patens".